Skip to main content

search

Commentary
Headlines
Research
Useful Links
About & Contact
Podcast

search

Wall Street Journal

By Kevin RocheDecember 14, 2010Headlines

No Comments

The FDA hasn’t yet weighed in on how pharma should be using social media and that, says a report from Deloitte, is one of the chief reasons more life sciences companies haven’t embraced social networking more aggressively.

Share this:

Twitter
Facebook
LinkedIn
Reddit

Tags:

✅ Subscribe via Email

Receive notifications of new posts by email.

Email Address

About this Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].

Healthy Skeptic Podcast

Subscribe to the Podcast

Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...

June 1, 2021

The Office of the Actuary annual report on national health spending, covering 2018.

December 7, 2019

2019 Kaiser Family Foundation Employer Health Benefits Report

October 1, 2019

MedPAC 2019 Report to Congress

June 18, 2019

Headlines

Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...

February 6, 2024

Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.

January 24, 2024

I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...

January 24, 2024

Mental health company Headway makes, well, headway, by raising an impressive $125 million round of new capital. The company connects patients with mental health providers and facilitates providers working with...

October 11, 2023

Tags

Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace

Previous PostHealth Leaders Media
Next PostNew York Times

Related Posts

Headlines

February 6, 2024

Cano

Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary…

Kevin Roche 0

Headlines

January 24, 2024

Turquoise

Turquoise health raises a fresh $30 million in capital for its price transparency platform, as…

Kevin Roche 0

Headlines

January 24, 2024

CAR-T safety

I am co-f0under of a company that manages cell and gene therapy for health plans.…

Kevin Roche 0

Leave a commentCancel reply

Share Tweet Share

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at [email protected]. © Roche Consulting, LLC. Terms of Use.

Categories

Commentary
Headlines
Research

Useful Links

Congressional Budget Office
Health Affairs

RSS Feed

© 2024 Healthy Skeptic.

twitter
facebook
linkedin

Commentary
Headlines
Research
Useful Links
About & Contact
Podcast